drugset
drugset / Trial / NCT03737656

Characterization of the Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal Women

NCT03737656 ↗

Phase 1 Completed 106 enrolled Grünenthal GmbH Grünenthal, S.A. · collab
RandomizedParallel-groupOpen-labelOther

Summary

This is a single site, open-label, randomized, single-dose, Phase 1 study in post-menopausal women.

Timeline

Start
2018-11-01
Primary completion
2019-05-03
Completion
2019-05-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 2 g Other

Indications

No indication recorded.